UPMC PASSAVANT — History
CCN 390107 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$395M
Latest Revenue (FY2022)
-3.6%
Revenue CAGR (3yr)
-23.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $424M | $397M | $395M | -0.6% | -3.6% |
| Operating Expenses | $414M | $455M | $486M | +6.8% | +8.3% |
| Operating Margin | 2.4% | -14.5% | -23.2% | -59.2% | +0.0% |
| Net Income | $10M | $-58M | $-91M | -58.2% | +0.0% |
| Licensed Beds | 385 | 355 | 354 | -0.3% | -4.1% |
| Total Patient Days | 74,688 | 73,440 | 72,524 | -1.2% | -1.5% |
| Medicare Day % | 24% | 23% | 22% | -3.6% | -4.2% |
| Medicaid Day % | 1% | 1% | 1% | -17.3% | -14.2% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.0% ($424M → $395M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.6%
This Hospital
+7.6%
State Avg
Latest Margin
-23.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $380M | -36.0% |
| FY2024 (proj) | $365M | -48.7% |
| FY2025 (proj) | $350M | -61.5% |